Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Hematology
•
Hemostasis/Thrombosis
•
Pulmonology
•
Pulmonary Vascular Disease
•
Pulmonary Embolus
How does your approach to subsegmental PE differ from segmental PE both diagnostically and therapeutically?
Related Questions
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
How do you manage concurrent nonlife-threatening hemoptysis and acute pulmonary embolism?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
Do you obtain an echocardiogram as a part of risk stratification in all patients hospitalized with an acute pulmonary embolism?
How do you follow pulmonary embolism patients who have completed anticoagulation?
In which cases would you consider early transition to DOAC (within 72 hours) for hospitalized patients with intermediate or high risk PE?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
How would you manage a patient pre-operatively with a prolonged PTT that does not correct on mixing, with lupus anticoagulant testing that is abnormal by LA-PTT only?
